HCQ debate: ICMR must conduct thorough RCTs, make findings public




A recent observational study led by a hospital in Italy claims that the anti-malarial drug reduced the risk of death amongst hospitalised Covid-19 patients by 30%.



Source link

Leave a Comment

Your email address will not be published.